R

Active Director Director DIN 08039897
DIN 08039897 First appointment Feb 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value •••• Premium profile

About Rajaram

Data last updated:

Rajaram is a Director at Zubnik Healthcare Private Limited (since 2018). The company operates in Healthcare. Zubnik Healthcare Private Limited reported revenue of ₹1.81 Cr (FY 2023).

DIN 08039897
Primary Designation Director
Industry Healthcare
First Appointment 17 Feb 2018
Oldest Company Age 8 yrs
Largest company Zubnik Healthcare Private Limited · ₹1.81 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zubnik Healthcare Private Limited U74999TN2018PTC120872
Director17 Feb 20182018₹1.81 Cr (FY 2023)Active

Board colleagues of Rajaram

Directorship timeline

Open interactive timeline →
Zubnik Healthcare Private Limited
Premium access

Shareholding and investment profile for Rajaram

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajaram

Rajaram currently holds 1 directorship: Zubnik Healthcare Private Limited (Director, since 17 Feb 2018, revenue ₹1.81 Cr (FY 2023)).

Rajaram was first appointed on 17 Feb 2018 as Director at Zubnik Healthcare Private Limited.

The current boards of Rajaram's companies include Gayathri (Zubnik Healthcare Private Limited), Rajaram Rengaraj (Zubnik Healthcare Private Limited), Swarnadevi (Zubnik Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available